{"transactions":[{"id":4631388,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":false,"shares":24587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Fully exercisable."}],"balance_after":41986,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":24587},"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4631387,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Fully exercisable."}],"balance_after":66573,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":413},"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4631386,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":8744,"price":116.5534,"value":1019142.9296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.39 to $117.22 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 150 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9938,"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4631385,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":15843,"price":116.1233,"value":1839741.4419,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.38 to $116.36 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 150 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":18682,"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4631384,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":true,"shares":24587,"price":8.27,"value":203334.49,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 150 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":34525,"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4631383,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":413,"price":115.5373,"value":47716.9049,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.30 to $115.615 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 150 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9938,"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4631382,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":413,"price":8.27,"value":3415.51,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 150 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":10351,"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4002,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"Fully exercisable."}],"balance_after":66986,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":4001,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":117,"price":113.38,"value":13265.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The closing price on September 1, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F11","text":"Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9938,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":4000,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"grant","planned":true,"acquired":true,"shares":150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":10055,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":3999,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"grant","planned":true,"acquired":true,"shares":150,"price":113.38,"value":17007.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9905,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":3998,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":2281,"price":115.6118,"value":263710.5158,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.37 to $115.82 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9755,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":3997,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":10989,"price":114.7118,"value":1260567.9702,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.365 to $115.295 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":12036,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":3996,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":11730,"price":113.9351,"value":1336458.723,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $113.36 to $114.34 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":23025,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":3995,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":8.27,"value":206750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":34755,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":674157,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-08-27T20:30:04.000Z","date":"2026-08-25","kind":"exercise","planned":true,"acquired":false,"shares":30955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Fully exercisable."}],"balance_after":169045,"derivative":{"exercise_price":11.35,"expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":30955},"source":{"system":"sec-edgar","filing":"0001193125-26-371388","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526371388/ownership.xml","form_type":"4"}},{"id":674156,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-27T20:30:04.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":5870,"price":126.0588,"value":739965.156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $126.00 to $126.23 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9755,"source":{"system":"sec-edgar","filing":"0001193125-26-371388","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526371388/ownership.xml","form_type":"4"}},{"id":674155,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-27T20:30:04.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":25085,"price":125.4676,"value":3147354.746,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $125.00 to $125.98 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":15625,"source":{"system":"sec-edgar","filing":"0001193125-26-371388","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526371388/ownership.xml","form_type":"4"}},{"id":674154,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-27T20:30:04.000Z","date":"2026-08-25","kind":"exercise","planned":true,"acquired":true,"shares":30955,"price":11.35,"value":351339.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":40710,"source":{"system":"sec-edgar","filing":"0001193125-26-371388","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526371388/ownership.xml","form_type":"4"}},{"id":684295,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-08-18T20:30:11.000Z","date":"2026-08-14","kind":"exercise","planned":true,"acquired":false,"shares":3664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Fully exercisable."}],"balance_after":91986,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":3664},"source":{"system":"sec-edgar","filing":"0001193125-26-355563","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526355563/ownership.xml","form_type":"4"}},{"id":684294,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-18T20:30:11.000Z","date":"2026-08-14","kind":"sale","planned":true,"acquired":false,"shares":3664,"price":114.49,"value":419491.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9755,"source":{"system":"sec-edgar","filing":"0001193125-26-355563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526355563/ownership.xml","form_type":"4"}},{"id":684293,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-18T20:30:11.000Z","date":"2026-08-14","kind":"exercise","planned":true,"acquired":true,"shares":3664,"price":8.27,"value":30301.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13419,"source":{"system":"sec-edgar","filing":"0001193125-26-355563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526355563/ownership.xml","form_type":"4"}},{"id":689783,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-08-12T20:27:23.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":false,"shares":1031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully exercisable."}],"balance_after":95650,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":1031},"source":{"system":"sec-edgar","filing":"0001193125-26-346951","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346951/ownership.xml","form_type":"4"}},{"id":689782,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-12T20:27:23.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":1031,"price":114.5182,"value":118068.2642,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.50 to $114.58 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9755,"source":{"system":"sec-edgar","filing":"0001193125-26-346951","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346951/ownership.xml","form_type":"4"}},{"id":689781,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-12T20:27:23.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":true,"shares":1031,"price":8.27,"value":8526.37,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":10786,"source":{"system":"sec-edgar","filing":"0001193125-26-346951","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346951/ownership.xml","form_type":"4"}},{"id":696184,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-08-05T21:51:36.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":20305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully exercisable."}],"balance_after":96681,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":20305},"source":{"system":"sec-edgar","filing":"0001193125-26-335617","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526335617/ownership.xml","form_type":"4"}},{"id":696183,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-05T21:51:36.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":20305,"price":114.7045,"value":2329074.8725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.49 to $115.00 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9755,"source":{"system":"sec-edgar","filing":"0001193125-26-335617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526335617/ownership.xml","form_type":"4"}},{"id":696182,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-05T21:51:36.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":20305,"price":8.27,"value":167922.35,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":30060,"source":{"system":"sec-edgar","filing":"0001193125-26-335617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526335617/ownership.xml","form_type":"4"}},{"id":716149,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-07-06T20:44:28.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Fully exercisable."}],"balance_after":116986,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-296296","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526296296/ownership.xml","form_type":"4"}},{"id":716148,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-07-06T20:44:28.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":11175,"price":89.3094,"value":998032.545,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $89.09 to $89.37 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9755,"source":{"system":"sec-edgar","filing":"0001193125-26-296296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526296296/ownership.xml","form_type":"4"}},{"id":716147,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-07-06T20:44:28.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":2801,"price":88.5127,"value":247924.0727,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $87.98 to $88.97 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":20930,"source":{"system":"sec-edgar","filing":"0001193125-26-296296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526296296/ownership.xml","form_type":"4"}},{"id":716146,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-07-06T20:44:28.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":11024,"price":87.3349,"value":962779.9376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $86.95 to $87.83 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":23731,"source":{"system":"sec-edgar","filing":"0001193125-26-296296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526296296/ownership.xml","form_type":"4"}},{"id":716145,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-07-06T20:44:28.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":8.27,"value":206750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":34755,"source":{"system":"sec-edgar","filing":"0001193125-26-296296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526296296/ownership.xml","form_type":"4"}},{"id":752882,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-06-03T23:20:53.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"Fully exercisable."}],"balance_after":141986,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-256013","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256013/ownership.xml","form_type":"4"}},{"id":752881,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-03T23:20:53.000Z","date":"2026-06-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":452,"price":70.44,"value":31838.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The closing price on June 1, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F10","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9755,"source":{"system":"sec-edgar","filing":"0001193125-26-256013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256013/ownership.xml","form_type":"4"}},{"id":752880,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-03T23:20:53.000Z","date":"2026-06-01","kind":"grant","planned":true,"acquired":true,"shares":615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":10207,"source":{"system":"sec-edgar","filing":"0001193125-26-256013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256013/ownership.xml","form_type":"4"}},{"id":752879,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-03T23:20:53.000Z","date":"2026-06-01","kind":"grant","planned":true,"acquired":true,"shares":615,"price":70.44,"value":43320.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on June 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9592,"source":{"system":"sec-edgar","filing":"0001193125-26-256013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256013/ownership.xml","form_type":"4"}},{"id":752878,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-03T23:20:53.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":3931,"price":70.7462,"value":278103.3122,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $70.49 to $70.95 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8977,"source":{"system":"sec-edgar","filing":"0001193125-26-256013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256013/ownership.xml","form_type":"4"}},{"id":752877,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-03T23:20:53.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":21069,"price":70.1068,"value":1477080.1692,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $69.49 to $70.48 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":12908,"source":{"system":"sec-edgar","filing":"0001193125-26-256013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256013/ownership.xml","form_type":"4"}},{"id":752876,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-03T23:20:53.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":8.27,"value":206750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":33977,"source":{"system":"sec-edgar","filing":"0001193125-26-256013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256013/ownership.xml","form_type":"4"}},{"id":759228,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-05-29T22:03:35.000Z","date":"2026-05-27","kind":"exercise","planned":true,"acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Fully exercisable."}],"balance_after":166986,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001193125-26-248967","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526248967/ownership.xml","form_type":"4"}},{"id":759227,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-29T22:03:35.000Z","date":"2026-05-27","kind":"sale","planned":true,"acquired":false,"shares":20425,"price":66.1599,"value":1351315.9575,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $66.00 to $66.50 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8977,"source":{"system":"sec-edgar","filing":"0001193125-26-248967","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526248967/ownership.xml","form_type":"4"}},{"id":759226,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-29T22:03:35.000Z","date":"2026-05-27","kind":"sale","planned":true,"acquired":false,"shares":54575,"price":65.3711,"value":3567627.7825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $65.00 to $65.99 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":29402,"source":{"system":"sec-edgar","filing":"0001193125-26-248967","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526248967/ownership.xml","form_type":"4"}},{"id":759225,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-29T22:03:35.000Z","date":"2026-05-27","kind":"exercise","planned":true,"acquired":true,"shares":75000,"price":8.27,"value":620250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":83977,"source":{"system":"sec-edgar","filing":"0001193125-26-248967","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526248967/ownership.xml","form_type":"4"}},{"id":863061,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-05T01:24:42.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":110,"price":35.97,"value":3956.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on March 2, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025 and 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8977,"source":{"system":"sec-edgar","filing":"0001193125-26-092164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526092164/ownership.xml","form_type":"4"}},{"id":863060,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-05T01:24:42.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025 and 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9087,"source":{"system":"sec-edgar","filing":"0001193125-26-092164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526092164/ownership.xml","form_type":"4"}},{"id":863059,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-05T01:24:42.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":454,"price":35.97,"value":16330.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on March 2, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025 and 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8633,"source":{"system":"sec-edgar","filing":"0001193125-26-092164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526092164/ownership.xml","form_type":"4"}},{"id":870157,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T23:14:56.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercise ratably in equal installments on each monthly anniversary of February 27, 2026 over a four-year period subject to the Reporting Person's continued service through each vesting date."}],"balance_after":140000,"derivative":{"exercise_price":35.7,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001193125-26-089013","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526089013/ownership.xml","form_type":"4"}},{"id":905857,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-13T21:25:58.000Z","date":"2026-01-08","kind":"other","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents the shares held by SNM 2026 Grantor Retained Annuity Trust of which the Reporting Person is the trustee."}],"balance_after":34000,"source":{"system":"sec-edgar","filing":"0001193125-26-051492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526051492/ownership.xml","form_type":"4"}},{"id":905856,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-13T21:25:58.000Z","date":"2026-01-08","kind":"gift","planned":false,"acquired":false,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee."}],"balance_after":5147,"source":{"system":"sec-edgar","filing":"0001193125-26-051492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526051492/ownership.xml","form_type":"4"}},{"id":905855,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-13T21:25:58.000Z","date":"2026-01-08","kind":"other","planned":false,"acquired":true,"shares":20570,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents the shares held by MMM 2025, LLC of which the Reporting Person is a member and manager."}],"balance_after":20570,"source":{"system":"sec-edgar","filing":"0001193125-26-051492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526051492/ownership.xml","form_type":"4"}},{"id":905854,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-13T21:25:58.000Z","date":"2026-01-08","kind":"gift","planned":false,"acquired":false,"shares":20570,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee."}],"balance_after":39147,"source":{"system":"sec-edgar","filing":"0001193125-26-051492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526051492/ownership.xml","form_type":"4"}},{"id":982406,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2025-12-04T01:53:43.000Z","date":"2025-12-01","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Fully exercisable."}],"balance_after":241986,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-25-307251","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307251/ownership.xml","form_type":"4"}},{"id":982405,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-04T01:53:43.000Z","date":"2025-12-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":135,"price":79.78,"value":10770.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The closing price on December 1, 2025 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8179,"source":{"system":"sec-edgar","filing":"0001193125-25-307251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307251/ownership.xml","form_type":"4"}},{"id":982404,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-04T01:53:43.000Z","date":"2025-12-01","kind":"grant","planned":true,"acquired":true,"shares":205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8314,"source":{"system":"sec-edgar","filing":"0001193125-25-307251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307251/ownership.xml","form_type":"4"}},{"id":982403,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-04T01:53:43.000Z","date":"2025-12-01","kind":"grant","planned":true,"acquired":true,"shares":205,"price":79.78,"value":16354.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8109,"source":{"system":"sec-edgar","filing":"0001193125-25-307251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307251/ownership.xml","form_type":"4"}},{"id":982402,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-04T01:53:43.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":79.5245,"value":1590490.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.40 to $79.81 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":7904,"source":{"system":"sec-edgar","filing":"0001193125-25-307251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307251/ownership.xml","form_type":"4"}},{"id":982401,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-04T01:53:43.000Z","date":"2025-12-01","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":8.27,"value":165400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":27904,"source":{"system":"sec-edgar","filing":"0001193125-25-307251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307251/ownership.xml","form_type":"4"}},{"id":1007182,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2025-11-06T00:56:37.000Z","date":"2025-11-03","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully exercisable."}],"balance_after":261986,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-25-267542","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525267542/ownership.xml","form_type":"4"}},{"id":1007181,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-06T00:56:37.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":73.9908,"value":1479816.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.47 to $74.27 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":7904,"source":{"system":"sec-edgar","filing":"0001193125-25-267542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525267542/ownership.xml","form_type":"4"}},{"id":1007180,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-06T00:56:37.000Z","date":"2025-11-03","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":8.27,"value":165400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":27904,"source":{"system":"sec-edgar","filing":"0001193125-25-267542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525267542/ownership.xml","form_type":"4"}},{"id":1025436,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2025-10-03T21:15:51.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":false,"shares":18014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully exercisable."}],"balance_after":281986,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":18014},"source":{"system":"sec-edgar","filing":"0001193125-25-230435","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525230435/ownership.xml","form_type":"4"}},{"id":1025435,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2025-10-03T21:15:51.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":false,"shares":1986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.05,"expiration_date":"2026-05-02","underlying":"Common Stock","underlying_shares":1986},"source":{"system":"sec-edgar","filing":"0001193125-25-230435","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525230435/ownership.xml","form_type":"4"}},{"id":1025434,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-03T21:15:51.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":2647,"price":85.5758,"value":226519.1426,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $85.41 to $85.79 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":7904,"source":{"system":"sec-edgar","filing":"0001193125-25-230435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525230435/ownership.xml","form_type":"4"}},{"id":1025433,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-03T21:15:51.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":16394,"price":85.0562,"value":1394411.3428,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $84.41 to $85.40 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":10551,"source":{"system":"sec-edgar","filing":"0001193125-25-230435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525230435/ownership.xml","form_type":"4"}},{"id":1025432,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-03T21:15:51.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":959,"price":83.7344,"value":80301.2896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $83.23 to $84.16 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":26945,"source":{"system":"sec-edgar","filing":"0001193125-25-230435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525230435/ownership.xml","form_type":"4"}},{"id":1025431,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-03T21:15:51.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":true,"shares":18014,"price":8.27,"value":148975.78,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":27904,"source":{"system":"sec-edgar","filing":"0001193125-25-230435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525230435/ownership.xml","form_type":"4"}},{"id":1025430,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-03T21:15:51.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":true,"shares":1986,"price":5.05,"value":10029.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9890,"source":{"system":"sec-edgar","filing":"0001193125-25-230435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525230435/ownership.xml","form_type":"4"}},{"id":1048528,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2025-09-04T23:54:51.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Fully exercisable."}],"balance_after":1986,"derivative":{"exercise_price":5.05,"expiration_date":"2026-05-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-25-196315","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196315/ownership.xml","form_type":"4"}},{"id":1048527,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-04T23:54:51.000Z","date":"2025-09-03","kind":"tax_withholding","planned":true,"acquired":false,"shares":233,"price":71.38,"value":16631.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The closing price on September 2, 2025 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":7904,"source":{"system":"sec-edgar","filing":"0001193125-25-196315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196315/ownership.xml","form_type":"4"}},{"id":1048526,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-04T23:54:51.000Z","date":"2025-09-02","kind":"grant","planned":true,"acquired":true,"shares":228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8137,"source":{"system":"sec-edgar","filing":"0001193125-25-196315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196315/ownership.xml","form_type":"4"}},{"id":1048525,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-04T23:54:51.000Z","date":"2025-09-02","kind":"grant","planned":true,"acquired":true,"shares":228,"price":71.38,"value":16274.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 2, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":7909,"source":{"system":"sec-edgar","filing":"0001193125-25-196315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196315/ownership.xml","form_type":"4"}},{"id":1048524,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-04T23:54:51.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":4930,"price":70.8359,"value":349220.987,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $70.72 to $71.09 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":7681,"source":{"system":"sec-edgar","filing":"0001193125-25-196315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196315/ownership.xml","form_type":"4"}},{"id":1048523,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-04T23:54:51.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":15070,"price":70.3787,"value":1060607.009,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $69.72 to $70.715 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":12611,"source":{"system":"sec-edgar","filing":"0001193125-25-196315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196315/ownership.xml","form_type":"4"}},{"id":1048522,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-04T23:54:51.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":5.05,"value":101000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":27681,"source":{"system":"sec-edgar","filing":"0001193125-25-196315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196315/ownership.xml","form_type":"4"}},{"id":1075271,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2025-08-05T22:51:38.000Z","date":"2025-08-01","kind":"exercise","planned":true,"acquired":false,"shares":35007,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Fully exercisable."}],"balance_after":21986,"derivative":{"exercise_price":5.05,"expiration_date":"2026-05-02","underlying":"Common Stock","underlying_shares":35007},"source":{"system":"sec-edgar","filing":"0000950170-25-103324","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025103324/ownership.xml","form_type":"4"}},{"id":1075270,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-05T22:51:38.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":1714,"price":69.7008,"value":119467.1712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $69.48 to $69.74 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":7681,"source":{"system":"sec-edgar","filing":"0000950170-25-103324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025103324/ownership.xml","form_type":"4"}},{"id":1075269,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-05T22:51:38.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":5428,"price":68.5247,"value":371952.0716,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $68.17 to $69.13 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":9395,"source":{"system":"sec-edgar","filing":"0000950170-25-103324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025103324/ownership.xml","form_type":"4"}},{"id":1075268,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-05T22:51:38.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":27865,"price":67.5334,"value":1881818.191,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $67.17 to $68.10 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":14823,"source":{"system":"sec-edgar","filing":"0000950170-25-103324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025103324/ownership.xml","form_type":"4"}},{"id":1075267,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-05T22:51:38.000Z","date":"2025-08-01","kind":"exercise","planned":true,"acquired":true,"shares":35007,"price":5.05,"value":176785.35,"ownership":{"direct":true},"balance_after":42688,"source":{"system":"sec-edgar","filing":"0000950170-25-103324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025103324/ownership.xml","form_type":"4"}},{"id":1075266,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-05T22:51:38.000Z","date":"2025-07-03","kind":"other","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Transfer of shares without consideration to the SNM 2025 Grantor Retained Annuity Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents the shares held by SNM 2025 Grantor Retained Annuity Trust of which the Reporting Person is the trustee."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0000950170-25-103324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025103324/ownership.xml","form_type":"4"}},{"id":1075265,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-05T22:51:38.000Z","date":"2025-07-03","kind":"gift","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee."}],"balance_after":59717,"source":{"system":"sec-edgar","filing":"0000950170-25-103324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025103324/ownership.xml","form_type":"4"}},{"id":1075264,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-05T22:51:38.000Z","date":"2025-06-12","kind":"other","planned":true,"acquired":true,"shares":10024,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transfer of shares without consideration to the Sean and Molly Maduck Living Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee."}],"balance_after":99717,"source":{"system":"sec-edgar","filing":"0000950170-25-103324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025103324/ownership.xml","form_type":"4"}},{"id":1075263,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-05T22:51:38.000Z","date":"2025-06-12","kind":"gift","planned":true,"acquired":false,"shares":10024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":7681,"source":{"system":"sec-edgar","filing":"0000950170-25-103324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025103324/ownership.xml","form_type":"4"}},{"id":1084251,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2025-07-21T23:14:32.000Z","date":"2025-07-18","kind":"exercise","planned":true,"acquired":false,"shares":473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully exercisable."}],"balance_after":56993,"derivative":{"exercise_price":5.05,"expiration_date":"2026-05-02","underlying":"Common Stock","underlying_shares":473},"source":{"system":"sec-edgar","filing":"0000950170-25-097374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025097374/ownership.xml","form_type":"4"}},{"id":1084250,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2025-07-21T23:14:32.000Z","date":"2025-07-17","kind":"exercise","planned":true,"acquired":false,"shares":4315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully exercisable."}],"balance_after":57466,"derivative":{"exercise_price":5.05,"expiration_date":"2026-05-02","underlying":"Common Stock","underlying_shares":4315},"source":{"system":"sec-edgar","filing":"0000950170-25-097374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025097374/ownership.xml","form_type":"4"}},{"id":1084249,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-07-21T23:14:32.000Z","date":"2025-07-18","kind":"sale","planned":true,"acquired":false,"shares":473,"price":73.4404,"value":34737.3092,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.40 to $73.47 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":17705,"source":{"system":"sec-edgar","filing":"0000950170-25-097374","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025097374/ownership.xml","form_type":"4"}},{"id":1084248,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-07-21T23:14:32.000Z","date":"2025-07-18","kind":"exercise","planned":true,"acquired":true,"shares":473,"price":5.05,"value":2388.65,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":18178,"source":{"system":"sec-edgar","filing":"0000950170-25-097374","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025097374/ownership.xml","form_type":"4"}},{"id":1084247,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-07-21T23:14:32.000Z","date":"2025-07-17","kind":"sale","planned":true,"acquired":false,"shares":4315,"price":73.4771,"value":317053.6865,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.40 to $73.74 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":17705,"source":{"system":"sec-edgar","filing":"0000950170-25-097374","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025097374/ownership.xml","form_type":"4"}},{"id":1084246,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-07-21T23:14:32.000Z","date":"2025-07-17","kind":"exercise","planned":true,"acquired":true,"shares":4315,"price":5.05,"value":21790.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":22020,"source":{"system":"sec-edgar","filing":"0000950170-25-097374","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025097374/ownership.xml","form_type":"4"}},{"id":1093068,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2025-07-04T00:35:29.000Z","date":"2025-07-01","kind":"exercise","planned":true,"acquired":false,"shares":205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully exercisable."}],"balance_after":61781,"derivative":{"exercise_price":5.05,"expiration_date":"2026-05-02","underlying":"Common Stock","underlying_shares":205},"source":{"system":"sec-edgar","filing":"0000950170-25-094120","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025094120/ownership.xml","form_type":"4"}},{"id":1093067,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-07-04T00:35:29.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":205,"price":73.4523,"value":15057.7215,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.40 to $73.62 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":17705,"source":{"system":"sec-edgar","filing":"0000950170-25-094120","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025094120/ownership.xml","form_type":"4"}},{"id":1093066,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-07-04T00:35:29.000Z","date":"2025-07-01","kind":"exercise","planned":true,"acquired":true,"shares":205,"price":5.05,"value":1035.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":17910,"source":{"system":"sec-edgar","filing":"0000950170-25-094120","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025094120/ownership.xml","form_type":"4"}},{"id":1123576,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2025-06-05T00:33:11.000Z","date":"2025-06-02","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Fully exercisable."}],"balance_after":61986,"derivative":{"exercise_price":5.05,"expiration_date":"2026-05-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-25-081933","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081933/ownership.xml","form_type":"4"}},{"id":1123575,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-05T00:33:11.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":1811,"price":80.7669,"value":146268.8559,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $80.585 to $81.00 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":17705,"source":{"system":"sec-edgar","filing":"0000950170-25-081933","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081933/ownership.xml","form_type":"4"}},{"id":1123574,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-05T00:33:11.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":6246,"price":79.8859,"value":498967.3314,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.5725 to $80.535 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":19516,"source":{"system":"sec-edgar","filing":"0000950170-25-081933","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081933/ownership.xml","form_type":"4"}},{"id":1123573,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-05T00:33:11.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":6191,"price":78.8744,"value":488311.4104,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $78.57 to $79.5675 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":25762,"source":{"system":"sec-edgar","filing":"0000950170-25-081933","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081933/ownership.xml","form_type":"4"}},{"id":1123572,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-05T00:33:11.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":5752,"price":77.9101,"value":448138.8952,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $77.56 to $78.515 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":31953,"source":{"system":"sec-edgar","filing":"0000950170-25-081933","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081933/ownership.xml","form_type":"4"}},{"id":1123571,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-05T00:33:11.000Z","date":"2025-06-02","kind":"grant","planned":true,"acquired":true,"shares":20000,"price":5.05,"value":101000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":37705,"source":{"system":"sec-edgar","filing":"0000950170-25-081933","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081933/ownership.xml","form_type":"4"}},{"id":1123570,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-05T00:33:11.000Z","date":"2025-06-02","kind":"grant","planned":true,"acquired":true,"shares":888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":17705,"source":{"system":"sec-edgar","filing":"0000950170-25-081933","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081933/ownership.xml","form_type":"4"}}],"next_cursor":"2025-06-05T00:33:11.000000Z,1123570"}